Sexual dysfunctions are frequent in men and women with diabetes (1). Erectile dysfunction (ED) is a common and debilitating complication of diabetes mellitus (DM) affecting up to 75% of men with long-standing disease (2, 3). The pathophysiology of ED in diabetes is multifactorial, involving endothelial dysfunction, neuropathy, hormonal imbalances, and psychological stressors (2, 3). Recent evidence has broadened the understanding of the intricate mechanisms behind ED, as well as its clinical implications and potential management strategies (2, 3). Glycaemic control, insulin resistance, hypogonadism, obesity, oxidative stress, adipokine imbalance, and inflammation, often present in diabetic patients, synergistically contribute to endothelial damage and compromised penile vascular flow (1, 2, 4). The same risk factors responsible for ED lead to early atherothrombosis (4). In fact, one of the most clinically significant associations highlighted in recent years is the link between ED and cardiovascular disease (4). Several studies suggest that ED may be an early marker of systemic atherosclerosis and future cardiovascular events in diabetic men (4). Although some studies suggested a correlation between ED and angiographic extent of coronary artery disease in men with diabetes, other ones did not confirm this finding (5). Similarly, ED is independently associated with silent myocardial ischemia in asymptomatic patients, suggesting a role for ED as a sentinel symptom to search for occult cardiovascular disease (6). Therapeutic approaches have expanded beyond pharmacotherapy. Lifestyle interventions, particularly those aimed at weight reduction, physical activity, and dietary improvement, have shown promising effects (7). Maiorino et al. reported results from the MÈDITA trial, showing that adherence to a Mediterranean diet improved erectile function in newly diagnosed diabetic patients, independently of weight loss and glycaemic control (8). These findings emphasize the potential of non-pharmacologic interventions in reversing or mitigating ED, particularly when implemented early (7). Interventions such as smoking cessation, exercise, and weight management have a consistent, albeit modest, positive impact on erectile function (7). These effects are particularly relevant in the diabetic population, where the burden of comorbidities and vascular disease is high. A few information is available in the literature about the impact that diabetes treatment can have of the occurrence of ED. Finally, ED in diabetes may also reflect the presence of microvascular complications. A recent study investigated the association of ED with presence and outcomes of diabetic foot, finding that men with diabetic foot have a very high prevalence of ED, and that patients with both conditions have worse outcomes, including higher rates of foot ulcer recurrence and lower limb amputation (9). Several mechanisms, including hormonal, psychological, nervous, and vascular changes, can lead to female sexual dysfunction (FSD) in women with diabetes, even if these mechanisms are now little understood (1, 10). In addition, it is not known the real prevalence and incidence of female sexual dysfunction in diabetes, and whether there is an association between sexual dysfunction and cardiovascular diseases (10). This suggests that new studies should clarify many aspects of FSD in women with diabetes
This Research Topic presents five pivotal studies that can contribute significantly to our understanding of ED and FSD in diabetes. All these studies explore the pathophysiological mechanisms, genetic associations, risk factors, and potential treatment strategies for ED, offering valuable insights for both research and clinical practice. One of these studies gives some interesting information about sexual health in diabetic women. The review by Ma et al. provides a comprehensive updated analysis of the diverse pathophysiological processes underlying ED in diabetes. In addition, it discusses current and emerging treatment modalities, advocating for a multidisciplinary approach to management (Ma et al.). In the study by Feng et al. the authors employed a two-sample Mendelian randomization approach to investigate the causal relationships between commonly used antidiabetic medications and the risk of ED. The systematic review and meta-analysis by Dilixiati et al. synthesizes data from multiple studies to identify key risk factors associated with ED in diabetic men. This updated analysis reveals that factors such as age, smoking, duration of diabetes, poor glycaemic control, depression, metabolic syndrome, hypertension, some medications, and the presence of diabetic complications significantly increase the risk of ED. These findings underscore the importance of comprehensive risk assessment and management in diabetic patients to reduce the risk for ED (Dilixiati et al.). The cross-sectional study by Yu et al. explores the relationship between obesity, lipid profiles, and testosterone levels in a large study population. The study finds that indices such as the Visceral Adiposity Index, Chinese Visceral Adiposity Index, Triglyceride Glucose Index, and Lipid Accumulation Product are significantly associated with hypogonadism in type 2 diabetic men. Sensitivity and specificity of each of four indices were better or not worse than those of body mass index, homeostasis model assessment of insulin resistance and waist circumference. All four indices were effective predictors of hypogonadism (Yu et al.). These findings confirm that metabolic health plays a crucial role in hormonal balance and sexual function. In the study by Jiang et al. researchers examine the causal effects of type 2 diabetes, fasting insulin, and HbA1c on testosterone levels in both men and women with diabetes. The study concludes that metabolic parameters are causally associated with abnormal testosterone levels in both sexes (Yu et al.). The associations were independent of obesity, BMI, TG, LDL and Adiponectin (Jiang et al.). This research highlights the importance of glycaemic management in preserving hormonal health and sexual function in men and women with diabetes.
The studies presented in this Research Topic collectively advance our understanding of the complex interplay between diabetes and sexual dysfunction in men and women. They emphasize the multifactorial nature of ED, the significance of personalized medicine, and the need for comprehensive management strategies that address metabolic, hormonal, and psychological aspects. Future research should continue to explore these dimensions to develop effective interventions that improve the quality of life for diabetic patients experiencing sexual dysfunction in both sexes.
Statements
Author contributions
AC: Writing – original draft, Writing – review & editing. KE: Writing – original draft, Writing – review & editing. CG: Writing – original draft, Writing – review & editing.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Generative AI statement
The author(s) declare that no Generative AI was used in the creation of this manuscript.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
MaiorinoMIBellastellaGGiuglianoDEspositoK. From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndrome. J Endocrinol Invest. (2018) 41:1249–58. doi: 10.1007/s40618-018-0872-6
2
DefeudisGMazzilliRTenutaMRossiniGZamponiVOlanaSet al. Erectile dysfunction and diabetes: A melting pot of circumstances and treatments. Diabetes Metab Res Rev. (2022) 38:e3494. doi: 10.1002/dmrr.3494
3
SaloniaACapogrossoPBoeriLCocciACoronaGDinkelman-SmitMet al. European association of urology guidelines on male sexual and reproductive health: 2025 update on male hypogonadism, erectile dysfunction, premature ejaculation, and peyronie’s disease. Eur Urol. (2025) 7:S0302-2838(25)00211-8. doi: 10.1016/j.eururo.2025.04.010
4
GazzarusoCCoppolaAGiustinaA. Erectile dysfunction and coronary artery disease in patients with diabetes. Curr Diabetes Rev. (2011) 7:143–7. doi: 10.2174/157339911794940693
5
GazzarusoCPujiaASolerteSBAmiciEDEmanueleEFalconeCet al. Erectile dysfunction and angiographic extent of coronary artery disease in type II diabetic patients. Int J Impot Res. (2006) 18:311–5. doi: 10.1038/sj.ijir.3901403
6
GazzarusoCGiordanettiSDe AmiciEBertoneGFalconeCGeroldiDet al. Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation. (2004) 110:22–6. doi: 10.1161/01.CIR.0000133278.81226.C9
7
MaiorinoMIBellastellaGEspositoK. Lifestyle modifications and erectile dysfunction: what can be expected? Asian J Androl. (2015) 17:5–10. doi: 10.4103/1008-682X.137687
8
MaiorinoMIBellastellaGCaputoMCastaldoFImprotaMRGiuglianoDet al. Effects of Mediterranean diet on sexual function in people with newly diagnosed type 2 diabetes: The MÈDITA trial. J Diabetes Complications. (2016) 30:1519–24. doi: 10.1016/j.jdiacomp.2016.08.007
9
CoppolaAGallottiPMontalciniTTerruzziIPujiaALuziLet al. Association of erectile dysfunction with diabetic foot and its outcomes in type 2 diabetic men. Hormones (Athens). (2023) 22:45–50. doi: 10.1007/s42000-022-00407-5
10
CoppolaAGallottiPChoussosDPujiaAMontalciniTGazzarusoC. Association between clitoral tissue perfusion and female sexual dysfunction in healthy women of reproductive age: a pilot study. Int J Impot Res. (2020) 32:221–5. doi: 10.1038/s41443-019-0155-6
Summary
Keywords
sexual dysfunction, erectile dysfunction, diabetes, female sexual dysfunction (FSD), cardiovascular risk
Citation
Coppola A, Esposito K and Gazzaruso C (2025) Editorial: Sexual function and dysfunction in men and women with diabetes. Front. Endocrinol. 16:1629375. doi: 10.3389/fendo.2025.1629375
Received
15 May 2025
Accepted
16 May 2025
Published
03 June 2025
Volume
16 - 2025
Edited and reviewed by
Åke Sjöholm, Gävle Hospital, Sweden
Updates
Copyright
© 2025 Coppola, Esposito and Gazzaruso.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Carmine Gazzaruso, carmine.gazzaruso@unimi.it
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.